India's CDMO market set to double by 2028 amid Asia's healthcare boom

India's CDMO market is set to grow from USD 7 billion to USD 14 billion by 2028. This growth is driven by its strong stance in API manufacturing and cost advantages over China. Global pharmaceutical companies are diversifying supply chains to India. The broader APAC healthcare sector is also expanding rapidly, supported by rising income levels.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1x7IKW2
via IFTTT